Peaccel
Business Services · France · 1-10 Employees
View Company Info for Free
Overview
Headquarters
33 Avenue Du Maine, Paris, Ile-de-France...Website
www.peaccel.comRevenue
$7 MillionIndustry
ZI Rank: 1
About Peaccel
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Peaccel your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Funding: Get notified immidiatlly once Peaccel has new funding data
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Click to see if Peaccel had a recent Job posting/layoffs
Earning: See what the market has to say on Peaccel recently announced quarterly report
Check if Peaccel has recently received funding, and reach out quickly before it becomes old news!
Check out if Peaccel is spiking on competitors!
Peaccel, which may be a good buyer, showed buying intent in Masked Content Topic
Website visits: Recent activity has been detected on your website
Congratulate Masked Content for being promoted to Masked Content at Peaccel
Product Launch: Get notified when Peaccel launches new products
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 2 more new buyers
Company Profile Activity
Activity Insights
Peaccel is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Peaccel is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Peaccel.
Peaccel Tech Stack
A closer look at the technologies used by Peaccel
Top Business Services Companies
Frequently Asked Questions Regarding Peaccel
Peaccel is an AI company focused on the life sciences sector, providing end-to-end solutions for drug discovery from hit identification to preclinical trials. They utilize dedicated AI tools to identify drug targets and optimize processes, such as enzyme or bioreactor yields, while reducing risks associated with patent loopholes. The company forms... Read More
